Kenvue announced a major change at the top July 14, along with actions to “unlock shareholder value and reach its full potential.” CEO Thibaut Mongon has departed the Summit-based company and ...

Board director Kirk Perry has been named interim CEO while the company ... Mongon’s departure follows the appointment of a new chief financial officer in May, when Amit Banati replaced Paul Ruh. In a ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim CEO on Monday.

By Sriparna Roy and Abigail Summerville (Reuters) -Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect ...

Kenvue KVUE 0.59%, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio ...

Kenvue KVUE2.01%increase; green up pointing triangle, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, named director Kirk Perry as interim chief executive officer. The Skillman, N.J ...

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29 Jul. 14, 2025 7:10 AM ET Kenvue Inc. (KVUE) Stock By: Meghavi Singh, SA News Editor 2 Comments Play (2min) ...

Kenvue, which makes powerhouse consumer health brands such as Listerine mouthwash and pain reliever Tylenol, saw its second-quarter sales slip 4%, the company also reported on Monday.

Kenvue said Monday that board member Kirk Perry will serve as interim CEO, effective immediately. Perry has served as a director since December and most recently served as CEO of Circana, a ...

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part ...